SIV Vaccine Success

A cytomegalovirus-based vaccine eliminated simian immunodeficiency virus from rhesus macaques, raising hopes of a similarly effective HIV vaccine.

Written byKate Yandell
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

SIV virionNIH, SRIRAM SUBRAMANIAMA vaccine has eliminated simian immunodeficiency virus (SIV) in some rhesus macaques, which remained uninfected for as long as three years post-treatment, according to a study published in Nature yesterday (September 12).

Previously, researchers had shown that about half of rhesus macaques given the vaccine were protected from SIV infection. The new study showed that monkeys given the vaccine and then infected with SIV showed no signs of the virus in their systems even though it had originally taken hold.

“The virus got in, it infected some cells, moved about in various parts of the body, but it was subsequently cleared, so that by two or three years later the monkeys looked like normal monkeys,” study coauthor Louis Picker from Oregon Health and Science University told Gizmodo.

The vaccine contains a cytomegalovirus that expresses SIV proteins, stimulating the immune system to recognize and attempt to eliminate the virus. The researchers now hope to determine whether the vaccine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies